Polycystic Ovary Syndrome (PCOS) Treatment Market to Reach US $1,154.8 Mn by 2024
Polycystic ovary syndrome (PCOS) is a common hormonal endocrine disorder that affects women of child bearing age (15 to 49 years). This disease is characterized by the formation of cysts on the ovaries leading to an insufficiency of the ovulation initiating hormone in the female body. The global market for PCOS drugs is on an upward swing given the increasing number of cases of patients inflicted with the disease. The global polycystic ovary syndrome drugs market revenue is estimated to...
View full press release